CGON holder plans 50,000-share stock sale

An affiliate of CGON, identified as Ambaw Bellete, filed a notice to sell 50,000 shares of common stock, to be delivered through a stock option exercise on 07/27/2026, with Morgan Stanley Smith Barney LLC Executive Financial Services as broker.

Rhea-AI Filing Summary

An affiliate of CGON, identified as Ambaw Bellete, filed a notice to sell 50,000 shares of common stock, to be delivered through a stock option exercise on 07/27/2026, with Morgan Stanley Smith Barney LLC Executive Financial Services as broker.

The planned 50,000-share sale is valued at $3,627,995.00. The filer also reports prior sales during the past three months, including 50,000 shares for $3,588,620.00 on 07/23/2026 and 52,438 shares for $3,816,007.65 on 07/15/2026.

Key Figures

Planned shares to be sold: 50,000 shares Planned sale value: $3,627,995.00 Past sale 1 shares: 50,000 shares +3 more

6 metrics

Planned shares to be sold 50,000 shares Common stock to be sold via stock option exercise on 07/27/2026

Planned sale value $3,627,995.00 Aggregate market value of 50,000 common shares to be sold

Past sale 1 shares 50,000 shares Common stock sold on 07/23/2026

Past sale 1 value $3,588,620.00 Aggregate market value for 50,000 shares sold on 07/23/2026

Past sale 2 shares 52,438 shares Common stock sold on 07/15/2026

Past sale 2 value $3,816,007.65 Aggregate market value for 52,438 shares sold on 07/15/2026

Key Terms

Securities To Be Sold, Stock Option Exercise, Securities Sold During The Past 3 Months

3 terms

Securities To Be Sold financial

"144: Securities To Be Sold"

Stock Option Exercise financial

"Common | 07/27/2026 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Securities Sold During The Past 3 Months financial

"144: Securities Sold During The Past 3 Months"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock sale is being proposed for CGON in this Form 144 filing?

The filer plans to sell 50,000 shares of CGON common stock, to be delivered via a stock option exercise dated 07/27/2026, using Morgan Stanley Smith Barney LLC Executive Financial Services as the broker handling the transaction.

What is the estimated value of the new 50,000-share CGON sale?

The proposed 50,000-share sale of CGON common stock is valued at approximately $3,627,995.00. This reflects the aggregate market value reported for the shares expected to be sold on 07/27/2026 through the designated brokerage account.

Who is the reporting person in the CGON Form 144 notice?

The reporting person is identified as Ambaw Bellete, with an address at 3000 Pegasus Park Drive, Suite 1640, Dallas, TX 75247. This individual is the holder proposing the sale of CGON common stock reported in the notice.

Which broker is handling the proposed CGON share sale?

The broker is Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004. This firm is listed in connection with the planned 50,000-share CGON common stock sale.

What CGON stock sales occurred in the past three months for this filer?

Reported past sales include 50,000 shares of CGON common stock for $3,588,620.00 on 07/23/2026 and 52,438 shares for $3,816,007.65 on 07/15/2026, both attributed to the same filer, Ambaw Bellete.

What type of transaction will deliver the 50,000 CGON shares for sale?

The 50,000 shares of CGON common stock to be sold are indicated as arising from a Stock Option Exercise with the issuer on 07/27/2026, with consideration listed as cash in the transaction details.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/27/2026 - 04:02 PM Accepted by SEC EDGAR 07/27/2026 - 04:02 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002007090
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CG ONCOLOGY, INC.
SEC File Number	001-41925
Address of Issuer	3000 Pegasus Park Drive SUITE 1640 Dallas TEXAS 75247
Phone	(949) 409-3700
Name of Person for Whose Account the Securities are To Be Sold	AMBAW BELLETE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	50000	3627995.00	88202473	07/27/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/27/2026	Stock Option Exercise	Issuer			50000	07/27/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
AMBAW BELLETE 3000 Pegasus Park Drive SUITE 1640 Dallas TX 75247	Common	07/23/2026	50000	3588620.00
AMBAW BELLETE 3000 Pegasus Park Drive SUITE 1640 Dallas TX 75247	Common	07/15/2026	52438	3816007.65

144: Remarks and Signature

Remarks
Date of Notice	07/27/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Ambaw Bellete
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)